This is consistent with our previous work in the PS19 mouse model of tauopathy and other studies reporting a reduction in microglial activation with attenuation or blockage of peripheral TNF-α signaling [18,41,42] and an increase in microglial activation with increased peripheral TNF-α signaling [46] in AD mouse models. The gene discussed is TNF; the disease is Alzheimer disease.